Immunosuppression
Deliberate prevention or diminution of the host's immune response. It may be nonspecific as in the administration of immunosuppressive agents (drugs or radiation) or by lymphocyte depletion or may be specific as in desensitization or the simultaneous administration of antigen and immunosuppressive drugs.
Immunosuppressive Agents
Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging.
Immune Tolerance
The specific failure of a normally responsive individual to make an immune response to a known antigen. It results from previous contact with the antigen by an immunologically immature individual (fetus or neonate) or by an adult exposed to extreme high-dose or low-dose antigen, or by exposure to radiation, antimetabolites, antilymphocytic serum, etc.
Graft Rejection
Tacrolimus
Cyclosporine
Graft Survival
Azathioprine
Mycophenolic Acid
An antibiotic substance derived from Penicillium stoloniferum, and related species. It blocks de novo biosynthesis of purine nucleotides by inhibition of the enzyme inosine monophosphate dehydrogenase. Mycophenolic acid is important because of its selective effects on the immune system. It prevents the proliferation of T-cells, lymphocytes, and the formation of antibodies from B-cells. It also may inhibit recruitment of leukocytes to inflammatory sites. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p1301)
Liver Transplantation
Transplantation, Homologous
Antilymphocyte Serum
Immunocompromised Host
Organ Transplantation
Transplantation Immunology
T-Lymphocytes
Lymphocytes responsible for cell-mediated immunity. Two types have been identified - cytotoxic (T-LYMPHOCYTES, CYTOTOXIC) and helper T-lymphocytes (T-LYMPHOCYTES, HELPER-INDUCER). They are formed when lymphocytes circulate through the THYMUS GLAND and differentiate to thymocytes. When exposed to an antigen, they divide rapidly and produce large numbers of new T cells sensitized to that antigen.
Calcineurin
A CALCIUM and CALMODULIN-dependent serine/threonine protein phosphatase that is composed of the calcineurin A catalytic subunit and the calcineurin B regulatory subunit. Calcineurin has been shown to dephosphorylate a number of phosphoproteins including HISTONES; MYOSIN LIGHT CHAIN; and the regulatory subunits of CAMP-DEPENDENT PROTEIN KINASES. It is involved in the regulation of signal transduction and is the target of an important class of immunophilin-immunosuppressive drug complexes.
Islets of Langerhans Transplantation
Transplantation Tolerance
Lymphoproliferative Disorders
Sirolimus
A macrolide compound obtained from Streptomyces hygroscopicus that acts by selectively blocking the transcriptional activation of cytokines thereby inhibiting cytokine production. It is bioactive only when bound to IMMUNOPHILINS. Sirolimus is a potent immunosuppressant and possesses both antifungal and antineoplastic properties.
Lymphocyte Activation
Morphologic alteration of small B LYMPHOCYTES or T LYMPHOCYTES in culture into large blast-like cells able to synthesize DNA and RNA and to divide mitotically. It is induced by INTERLEUKINS; MITOGENS such as PHYTOHEMAGGLUTININS, and by specific ANTIGENS. It may also occur in vivo as in GRAFT REJECTION.
Treatment Outcome
Transplantation
Muromonab-CD3
Tissue Donors
T-Lymphocytes, Regulatory
Cyclosporins
A group of closely related cyclic undecapeptides from the fungi Trichoderma polysporum and Cylindocarpon lucidum. They have some antineoplastic and antifungal action and significant immunosuppressive effects. Cyclosporins have been proposed as adjuvants in tissue and organ transplantation to suppress graft rejection.
Ultraviolet Rays
That portion of the electromagnetic spectrum immediately below the visible range and extending into the x-ray frequencies. The longer wavelengths (near-UV or biotic or vital rays) are necessary for the endogenous synthesis of vitamin D and are also called antirachitic rays; the shorter, ionizing wavelengths (far-UV or abiotic or extravital rays) are viricidal, bactericidal, mutagenic, and carcinogenic and are used as disinfectants.
Polyomavirus Infections
Postoperative Complications
Drug Therapy, Combination
Opportunistic Infections
Antibody Formation
Dermatitis, Contact
Retrospective Studies
Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons.
Immunocompetence
Lymphocytes
White blood cells formed in the body's lymphoid tissue. The nucleus is round or ovoid with coarse, irregularly clumped chromatin while the cytoplasm is typically pale blue with azurophilic (if any) granules. Most lymphocytes can be classified as either T or B (with subpopulations of each), or NATURAL KILLER CELLS.
Prednisone
Immune System
BK Virus
Immunity, Cellular
Steroids
A group of polycyclic compounds closely related biochemically to TERPENES. They include cholesterol, numerous hormones, precursors of certain vitamins, bile acids, alcohols (STEROLS), and certain natural drugs and poisons. Steroids have a common nucleus, a fused, reduced 17-carbon atom ring system, cyclopentanoperhydrophenanthrene. Most steroids also have two methyl groups and an aliphatic side-chain attached to the nucleus. (From Hawley's Condensed Chemical Dictionary, 11th ed)
Lung Transplantation
Skin Transplantation
Prednisolone
Cytomegalovirus Infections
Transplantation Chimera
Anemia, Aplastic
Biopsy
Cyclophosphamide
Precursor of an alkylating nitrogen mustard antineoplastic and immunosuppressive agent that must be activated in the LIVER to form the active aldophosphamide. It has been used in the treatment of LYMPHOMA and LEUKEMIA. Its side effect, ALOPECIA, has been used for defleecing sheep. Cyclophosphamide may also cause sterility, birth defects, mutations, and cancer.
Interleukin-10
A cytokine produced by a variety of cell types, including T-LYMPHOCYTES; MONOCYTES; DENDRITIC CELLS; and EPITHELIAL CELLS that exerts a variety of effects on immunoregulation and INFLAMMATION. Interleukin-10 combines with itself to form a homodimeric molecule that is the biologically active form of the protein.
CD4-Positive T-Lymphocytes
A critical subpopulation of T-lymphocytes involved in the induction of most immunological functions. The HIV virus has selective tropism for the T4 cell which expresses the CD4 phenotypic marker, a receptor for HIV. In fact, the key element in the profound immunosuppression seen in HIV infection is the depletion of this subset of T-lymphocytes.
Graft vs Host Disease
Follow-Up Studies
Bone Marrow Transplantation
Cytokines
Non-antibody proteins secreted by inflammatory leukocytes and some non-leukocytic cells, that act as intercellular mediators. They differ from classical hormones in that they are produced by a number of tissue or cell types rather than by specialized glands. They generally act locally in a paracrine or autocrine rather than endocrine manner.
Transplants
Histocompatibility Testing
Identification of the major histocompatibility antigens of transplant DONORS and potential recipients, usually by serological tests. Donor and recipient pairs should be of identical ABO blood group, and in addition should be matched as closely as possible for HISTOCOMPATIBILITY ANTIGENS in order to minimize the likelihood of allograft rejection. (King, Dictionary of Genetics, 4th ed)
Erythema
Lymphocyte Depletion
Flow Cytometry
Technique using an instrument system for making, processing, and displaying one or more measurements on individual cells obtained from a cell suspension. Cells are usually stained with one or more fluorescent dyes specific to cell components of interest, e.g., DNA, and fluorescence of each cell is measured as it rapidly transverses the excitation beam (laser or mercury arc lamp). Fluorescence provides a quantitative measure of various biochemical and biophysical properties of the cell, as well as a basis for cell sorting. Other measurable optical parameters include light absorption and light scattering, the latter being applicable to the measurement of cell size, shape, density, granularity, and stain uptake.
Measles virus
Interferon-gamma
The major interferon produced by mitogenically or antigenically stimulated LYMPHOCYTES. It is structurally different from TYPE I INTERFERON and its major activity is immunoregulation. It has been implicated in the expression of CLASS II HISTOCOMPATIBILITY ANTIGENS in cells that do not normally produce them, leading to AUTOIMMUNE DISEASES.
Immunity
Liver Failure
Severe inability of the LIVER to perform its normal metabolic functions, as evidenced by severe JAUNDICE and abnormal serum levels of AMMONIA; BILIRUBIN; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; LACTATE DEHYDROGENASES; and albumin/globulin ratio. (Blakiston's Gould Medical Dictionary, 4th ed)
Tumor Virus Infections
Dendritic Cells
Specialized cells of the hematopoietic system that have branch-like extensions. They are found throughout the lymphatic system, and in non-lymphoid tissues such as SKIN and the epithelia of the intestinal, respiratory, and reproductive tracts. They trap and process ANTIGENS, and present them to T-CELLS, thereby stimulating CELL-MEDIATED IMMUNITY. They are different from the non-hematopoietic FOLLICULAR DENDRITIC CELLS, which have a similar morphology and immune system function, but with respect to humoral immunity (ANTIBODY PRODUCTION).
Histocompatibility
Disease Models, Animal
Transplantation Conditioning
Dermatitis, Irritant
Indoleamine-Pyrrole 2,3,-Dioxygenase
Lymphocyte Culture Test, Mixed
Measure of histocompatibility at the HL-A locus. Peripheral blood lymphocytes from two individuals are mixed together in tissue culture for several days. Lymphocytes from incompatible individuals will stimulate each other to proliferate significantly (measured by tritiated thymidine uptake) whereas those from compatible individuals will not. In the one-way MLC test, the lymphocytes from one of the individuals are inactivated (usually by treatment with MITOMYCIN or radiation) thereby allowing only the untreated remaining population of cells to proliferate in response to foreign histocompatibility antigens.
Facial Transplantation
Antibodies, Neoplasm
Kidney
Risk Factors
Immunotherapy
Graft vs Host Reaction
Cells, Cultured
Hemolytic Plaque Technique
A method to identify and enumerate cells that are synthesizing ANTIBODIES against ANTIGENS or HAPTENS conjugated to sheep RED BLOOD CELLS. The sheep red blood cells surrounding cells secreting antibody are lysed by added COMPLEMENT producing a clear zone of HEMOLYSIS. (From Illustrated Dictionary of Immunology, 3rd ed)
Infection
Sunscreening Agents
Hematopoietic Stem Cell Transplantation
Transfer of HEMATOPOIETIC STEM CELLS from BONE MARROW or BLOOD between individuals within the same species (TRANSPLANTATION, HOMOLOGOUS) or transfer within the same individual (TRANSPLANTATION, AUTOLOGOUS). Hematopoietic stem cell transplantation has been used as an alternative to BONE MARROW TRANSPLANTATION in the treatment of a variety of neoplasms.
Hand Transplantation
Skin
Hypersensitivity, Delayed
Antigens, CD
Differentiation antigens residing on mammalian leukocytes. CD stands for cluster of differentiation, which refers to groups of monoclonal antibodies that show similar reactivity with certain subpopulations of antigens of a particular lineage or differentiation stage. The subpopulations of antigens are also known by the same CD designation.
Whole-Body Irradiation
Isoantigens
HIV Infections
Leukocyte Count
Transplantation, Isogeneic
Immunoconjugates
Combinations of diagnostic or therapeutic substances linked with specific immune substances such as IMMUNOGLOBULINS; MONOCLONAL ANTIBODIES; or ANTIGENS. Often the diagnostic or therapeutic substance is a radionuclide. These conjugates are useful tools for specific targeting of DRUGS and RADIOISOTOPES in the CHEMOTHERAPY and RADIOIMMUNOTHERAPY of certain cancers.
Graft Enhancement, Immunologic
The induction of prolonged survival and growth of allografts of either tumors or normal tissues which would ordinarily be rejected. It may be induced passively by introducing graft-specific antibodies from previously immunized donors, which bind to the graft's surface antigens, masking them from recognition by T-cells; or actively by prior immunization of the recipient with graft antigens which evoke specific antibodies and form antigen-antibody complexes which bind to the antigen receptor sites of the T-cells and block their cytotoxic activity.
CD8-Positive T-Lymphocytes
Incidence
Virus Activation
The mechanism by which latent viruses, such as genetically transmitted tumor viruses (PROVIRUSES) or PROPHAGES of lysogenic bacteria, are induced to replicate and then released as infectious viruses. It may be effected by various endogenous and exogenous stimuli, including B-cell LIPOPOLYSACCHARIDES, glucocorticoid hormones, halogenated pyrimidines, IONIZING RADIATION, ultraviolet light, and superinfecting viruses.
CD4 Lymphocyte Count
Sunburn
Immunoglobulin G
Dermatitis, Photoallergic
A delayed hypersensitivity involving the reaction between sunlight or other radiant energy source and a chemical substance to which the individual has been previously exposed and sensitized. It manifests as a papulovesicular, eczematous, or exudative dermatitis occurring chiefly on the light-exposed areas of the skin.
B-Lymphocytes
Interleukin-2
Isoantibodies
Concanavalin A
Kidney Failure, Chronic
The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION.
Tumor Escape
The ability of tumors to evade destruction by the IMMUNE SYSTEM. Theories concerning possible mechanisms by which this takes place involve both cellular immunity (IMMUNITY, CELLULAR) and humoral immunity (ANTIBODY FORMATION), and also costimulatory pathways related to CD28 antigens (ANTIGENS, CD28) and CD80 antigens (ANTIGENS, CD80).
Chimerism
Immunomodulation
Alteration of the immune system or of an immune response by agents that activate or suppress its function. This can include IMMUNIZATION or administration of immunomodulatory drugs. Immunomodulation can also encompass non-therapeutic alteration of the immune system effected by endogenous or exogenous substances.
Prospective Studies
Macrophages
The relatively long-lived phagocytic cell of mammalian tissues that are derived from blood MONOCYTES. Main types are PERITONEAL MACROPHAGES; ALVEOLAR MACROPHAGES; HISTIOCYTES; KUPFFER CELLS of the liver; and OSTEOCLASTS. They may further differentiate within chronic inflammatory lesions to EPITHELIOID CELLS or may fuse to form FOREIGN BODY GIANT CELLS or LANGHANS GIANT CELLS. (from The Dictionary of Cell Biology, Lackie and Dow, 3rd ed.)
Chronic Disease
Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care. (Dictionary of Health Services Management, 2d ed)
Autoimmune Diseases
Blood Group Incompatibility
An antigenic mismatch between donor and recipient blood. Antibodies present in the recipient's serum may be directed against antigens in the donor product. Such a mismatch may result in a transfusion reaction in which, for example, donor blood is hemolyzed. (From Saunders Dictionary & Encyclopedia of Laboratory Medicine and Technology, 1984).
Fatal Outcome
Neoplasms
Epstein-Barr Virus Infections
Survival Rate
Mice, Inbred Strains
Genetically identical individuals developed from brother and sister matings which have been carried out for twenty or more generations, or by parent x offspring matings carried out with certain restrictions. All animals within an inbred strain trace back to a common ancestor in the twentieth generation.
Heart-Lung Transplantation
Lymph Nodes
Receptors, Interleukin-2
Receptors present on activated T-LYMPHOCYTES and B-LYMPHOCYTES that are specific for INTERLEUKIN-2 and play an important role in LYMPHOCYTE ACTIVATION. They are heterotrimeric proteins consisting of the INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT, the INTERLEUKIN-2 RECEPTOR BETA SUBUNIT, and the INTERLEUKIN RECEPTOR COMMON GAMMA-CHAIN.
Pneumonia, Pneumocystis
A pulmonary disease in humans occurring in immunodeficient or malnourished patients or infants, characterized by DYSPNEA, tachypnea, and HYPOXEMIA. Pneumocystis pneumonia is a frequently seen opportunistic infection in AIDS. It is caused by the fungus PNEUMOCYSTIS JIROVECII. The disease is also found in other MAMMALS where it is caused by related species of Pneumocystis.
Myeloid Cells
Immunologic Factors
Diabetes Mellitus, Type 1
A subtype of DIABETES MELLITUS that is characterized by INSULIN deficiency. It is manifested by the sudden onset of severe HYPERGLYCEMIA, rapid progression to DIABETIC KETOACIDOSIS, and DEATH unless treated with insulin. The disease may occur at any age, but is most common in childhood or adolescence.
HLA Antigens
Killer Cells, Natural
Bone marrow-derived lymphocytes that possess cytotoxic properties, classically directed against transformed and virus-infected cells. Unlike T CELLS; and B CELLS; NK CELLS are not antigen specific. The cytotoxicity of natural killer cells is determined by the collective signaling of an array of inhibitory and stimulatory CELL SURFACE RECEPTORS. A subset of T-LYMPHOCYTES referred to as NATURAL KILLER T CELLS shares some of the properties of this cell type.
Plasmapheresis
Sepsis
Systemic inflammatory response syndrome with a proven or suspected infectious etiology. When sepsis is associated with organ dysfunction distant from the site of infection, it is called severe sepsis. When sepsis is accompanied by HYPOTENSION despite adequate fluid infusion, it is called SEPTIC SHOCK.
Cytomegalovirus
A genus of the family HERPESVIRIDAE, subfamily BETAHERPESVIRINAE, infecting the salivary glands, liver, spleen, lungs, eyes, and other organs, in which they produce characteristically enlarged cells with intranuclear inclusions. Infection with Cytomegalovirus is also seen as an opportunistic infection in AIDS.
Antibodies, Monoclonal, Humanized
Antibodies from non-human species whose protein sequences have been modified to make them nearly identical with human antibodies. If the constant region and part of the variable region are replaced, they are called humanized. If only the constant region is modified they are called chimeric. INN names for humanized antibodies end in -zumab.
Glucocorticoids
A group of CORTICOSTEROIDS that affect carbohydrate metabolism (GLUCONEOGENESIS, liver glycogen deposition, elevation of BLOOD SUGAR), inhibit ADRENOCORTICOTROPIC HORMONE secretion, and possess pronounced anti-inflammatory activity. They also play a role in fat and protein metabolism, maintenance of arterial blood pressure, alteration of the connective tissue response to injury, reduction in the number of circulating lymphocytes, and functioning of the central nervous system.
Thymus Gland
A single, unpaired primary lymphoid organ situated in the MEDIASTINUM, extending superiorly into the neck to the lower edge of the THYROID GLAND and inferiorly to the fourth costal cartilage. It is necessary for normal development of immunologic function early in life. By puberty, it begins to involute and much of the tissue is replaced by fat.
Interleukin-12
A heterodimeric cytokine that plays a role in innate and adaptive immune responses. Interleukin-12 is a 70 kDa protein that is composed of covalently linked 40 kDa and 35 kDa subunits. It is produced by DENDRITIC CELLS; MACROPHAGES and a variety of other immune cells and plays a role in the stimulation of INTERFERON-GAMMA production by T-LYMPHOCYTES and NATURAL KILLER CELLS.
Survival Analysis
A class of statistical procedures for estimating the survival function (function of time, starting with a population 100% well at a given time and providing the percentage of the population still well at later times). The survival analysis is then used for making inferences about the effects of treatments, prognostic factors, exposures, and other covariates on the function.
Leukocytes, Mononuclear
T-Lymphocyte Subsets
Immunologic Deficiency Syndromes
Transplantation, Heterotopic
Dose-Response Relationship, Radiation
Measles
Phytohemagglutinins
Antiviral Agents
Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly.
Langerhans Cells
Recirculating, dendritic, antigen-presenting cells containing characteristic racket-shaped granules (Birbeck granules). They are found principally in the stratum spinosum of the EPIDERMIS and are rich in Class II MAJOR HISTOCOMPATIBILITY COMPLEX molecules. Langerhans cells were the first dendritic cell to be described and have been a model of study for other dendritic cells (DCs), especially other migrating DCs such as dermal DCs and INTERSTITIAL DENDRITIC CELLS.
Photopheresis
A process in which peripheral blood is exposed in an extracorporeal flow system to photoactivated 8-methoxypsoralen (METHOXSALEN) and ultraviolet light - a procedure known as PUVA THERAPY. Photopheresis is at present a standard therapy for advanced cutaneous T-cell lymphoma; it shows promise in the treatment of autoimmune diseases.
Hepatitis C
INFLAMMATION of the LIVER in humans caused by HEPATITIS C VIRUS, a single-stranded RNA virus. Its incubation period is 30-90 days. Hepatitis C is transmitted primarily by contaminated blood parenterally, and is often associated with transfusion and intravenous drug abuse. However, in a significant number of cases, the source of hepatitis C infection is unknown.
Mice, Knockout
Strains of mice in which certain GENES of their GENOMES have been disrupted, or "knocked-out". To produce knockouts, using RECOMBINANT DNA technology, the normal DNA sequence of the gene being studied is altered to prevent synthesis of a normal gene product. Cloned cells in which this DNA alteration is successful are then injected into mouse EMBRYOS to produce chimeric mice. The chimeric mice are then bred to yield a strain in which all the cells of the mouse contain the disrupted gene. Knockout mice are used as EXPERIMENTAL ANIMAL MODELS for diseases (DISEASE MODELS, ANIMAL) and to clarify the functions of the genes.
Dose-Response Relationship, Immunologic
Leukoencephalopathy, Progressive Multifocal
An opportunistic viral infection of the central nervous system associated with conditions that impair cell-mediated immunity (e.g., ACQUIRED IMMUNODEFICIENCY SYNDROME and other IMMUNOLOGIC DEFICIENCY SYNDROMES; HEMATOLOGIC NEOPLASMS; IMMUNOSUPPRESSION; and COLLAGEN DISEASES). The causative organism is JC Polyomavirus (JC VIRUS) which primarily affects oligodendrocytes, resulting in multiple areas of demyelination. Clinical manifestations include DEMENTIA; ATAXIA; visual disturbances; and other focal neurologic deficits, generally progressing to a vegetative state within 6 months. (From Joynt, Clinical Neurology, 1996, Ch26, pp36-7)
Postoperative Care
Hepatitis, Autoimmune
Influenzavirus A
Suppressor Factors, Immunologic
Proteins, protein complexes, or glycoproteins secreted by suppressor T-cells that inhibit either subsequent T-cells, B-cells, or other immunologic phenomena. Some of these factors have both histocompatibility (I-J) and antigen-specific domains which may be linked by disulfide bridges. They can be elicited by haptens or other antigens and may be mass-produced by hybridomas or monoclones in the laboratory.
Pemphigoid, Benign Mucous Membrane
Xeroderma Pigmentosum Group A Protein
AIDS-Related Opportunistic Infections
Opportunistic infections found in patients who test positive for human immunodeficiency virus (HIV). The most common include PNEUMOCYSTIS PNEUMONIA, Kaposi's sarcoma, cryptosporidiosis, herpes simplex, toxoplasmosis, cryptococcosis, and infections with Mycobacterium avium complex, Microsporidium, and Cytomegalovirus.
Cell Transplantation
Acquired Immunodeficiency Syndrome
An acquired defect of cellular immunity associated with infection by the human immunodeficiency virus (HIV), a CD4-positive T-lymphocyte count under 200 cells/microliter or less than 14% of total lymphocytes, and increased susceptibility to opportunistic infections and malignant neoplasms. Clinical manifestations also include emaciation (wasting) and dementia. These elements reflect criteria for AIDS as defined by the CDC in 1993.
Ganciclovir
Antibodies, Monoclonal, Murine-Derived
Models, Animal
Viral Load
Forkhead Transcription Factors
Drug Administration Schedule
Herpesvirus 4, Human
Possible suppression of host resistance by estrogen therapy for prostatic cancer.(1/3650)
(+info)Suppression of Moloney sarcoma virus immunity following sensitization with attenuated virus. (2/3650)
Murine sarcoma virus (Moloney strain) (MSV-M)-induced tumors are unusual in that they regularly appear less than 2 weeks after virus inoculation, progress for 1 to 2 weeks, and are rejected by normal adult BALB/c mice. Rejectio leaves the animals immune to tumor induction. In the present study, presensitization of normal adult BALB/c mice with attenuated MSV-M resulted in an altered pattern of tumor immunity. Injection of active MSV-M into the presensitized animals resulted in tumor induction and rejection similar to that observed in normal animals, but rejection failed to produce protection against the secondary inoculation with MSV-M. After the second inoculation with active MSV-M, tumors appeared and progressed but ultimately were rejected. Over 80% of the mice died, 25% after the primary challenge and the remainder after the secondary challenge. At death, all mice had histological evidence of leukemia which was the probable cause of death. The animals that died following the secondary challenge also had evidence of disseminated MSV-M. Solid tumor nodules were found in skeletal muscle distant from the original site of inoculation, and active MSV-M was isolated from spleen and lungs. The possibility that the results were produced by specific suppression of MSV-Moloney leukemia virus immunity is discussed. (+info)Infectious complications in 126 patients treated with high-dose chemotherapy and autologous peripheral blood stem cell transplantation. (3/3650)
The effect of an extensive prophylactic antimicrobial regimen was prospectively assessed in 126 patients after high-dose chemotherapy and autologous PBSC. They received ciprofloxacin (500 mg/12 h), acyclovir (200 mg/6 h), and itraconazole (200 mg/12 h) orally until neutrophil recovery. Febrile patients received i.v. imipenem (500 mg/6 h) to which vancomycin and amikacin were added if fever persisted for 2-3 and 5 days, respectively. Amphotericin B lipid complex was further given on day 7 or 8 of fever. Median times for a neutrophil count of >0.5 x 10(9)/l and a platelet count of >20 x 10(9)/l were 9 and 11 days. Severe neutropenia (<0.1 x 10(9)/l) lasted for a median of 5 days in which 72% of febrile episodes and 50% of cases of bacteremia occurred. Gram-positive bacteria were isolated in 30 of 40 episodes of bacteremia, 25 of which were caused by Staphylococcus epidermidis. Clinical foci were the intravascular catheter in 35 cases, respiratory infection in 11, cellulitis in two, anal abscess in one, and neutropenic enterocolitis in one. The high incidence of febrile episodes (94%) and bacteremias (31%) may be due to the lack of efficacy of antimicrobial prophylaxis and the persistence of a 5-day period of severe neutropenia. (+info)Rapid autologous marrow recovery and eradication of infectious mononucleosis despite severe immunosuppression following second transplantation for aplastic anemia. (4/3650)
A patient with aplastic anemia failed to respond to immunosuppressive therapy and first marrow transplantation (BMT). Recovery of autologous hematopoiesis was rapid following a second stem cell transplant with a non-myeloablative preparatory regimen. The autologous immune response to infectious mononucleosis (IM) 4 weeks post-transplant was normal despite recent and ongoing severe immunosuppression. (+info)A phase I and pharmacokinetic study of losoxantrone and paclitaxel in patients with advanced solid tumors. (5/3650)
A Phase I and pharmacological study was performed to evaluate the feasibility, maximum tolerated dose (MTD), dose-limiting toxicities (DLTs), and pharmacokinetics of the anthrapyrazole losoxantrone in combination with paclitaxel in adult patients with advanced solid malignancies. Losoxantrone was administered as a 10-min infusion in combination with paclitaxel on either a 24- or 3-h schedule. The starting dose level was 40 mg/m2 losoxantrone and 135 mg/m2 paclitaxel (as a 24- or 3-h i.v. infusion) without granulocyte colony-stimulating factor (G-CSF). Administration of these agents at the starting dose level and dose escalation was feasible only with G-CSF support. The following dose levels (losoxantrone/paclitaxel, in mg/m2) of losoxantrone and paclitaxel as a 3-h infusion were also evaluated: 50/135, 50/175, 50/200, 50/225, and 60/225. The sequence-dependent toxicological and pharmacological effects of losoxantrone and paclitaxel on the 24- and 3-h schedules of paclitaxel were also assessed. The MTD was defined as the dose at which >50% of the patients experienced DLT during the first two courses of therapy. DLTs, mainly myelosuppression, occurring during the first course of therapy were noted in four of six and five of eight patients treated with 40 mg/m2 losoxantrone and 135 mg/m2 paclitaxel over 24 and 3 h, respectively, without G-CSF. DLTs during the first two courses of therapy were observed in one of six patients at the 50/175 (losoxantrone/paclitaxel) mg/m2 dose level, two of four patients at the 50/200 mg/m2 dose level, one of four patients at the 50/225 mg/m2 dose level, and two of five patients at the 60/225 mg/m2 dose level. The degree of thrombocytopenia was worse, albeit not statistically significant, when 24-h paclitaxel preceded losoxantrone, with a mean percentage decrement in platelet count during course 1 of 80.7%, compared to 43.8% with the reverse sequence (P = 0.19). Losoxantrone clearance was not significantly altered by the sequence or schedule of paclitaxel. Cardiac toxicity was observed; however, it was not related to total cumulative dose of losoxantrone. An unacceptably high rate of DLTs at the first dose level of 40 mg/m2 losoxantrone and 135 mg/m2 paclitaxel administered as either a 24- or 3-h i.v. infusion precluded dose escalation without G-CSF support. The addition of G-CSF to the regimen permitted further dose escalation without reaching the MTD. Losoxantrone at 50 mg/m2 followed by paclitaxel (3-h i.v. infusion) at 175 mg/m2 with G-CSF support is recommended for further clinical trials. (+info)Efficient IgG-mediated suppression of primary antibody responses in Fcgamma receptor-deficient mice. (6/3650)
IgG antibodies can suppress more than 99% of the antibody response against the antigen to which they bind. This is used clinically to prevent rhesus-negative (Rh-) women from becoming immunized against Rh+ erythrocytes from their fetuses. The suppressive mechanism is poorly understood, but it has been proposed that IgG/erythrocyte complexes bind to the inhibitory Fc receptor for IgG (FcgammaRIIB) on the B cell surface, thereby triggering negative signals that turn off the B cell. We show that IgG induces the same degree of suppression of the response to sheep erythrocytes in animals lacking the known IgG-binding receptors FcgammaRIIB, FcgammaRI + III, FcgammaRI + IIB + III, and FcRn (the neonatal Fc receptor) as in wild-type animals. Reinvestigation of the ability of F(ab')2 fragments to suppress antibody responses demonstrated that they were nearly as efficient as intact IgG. In addition, monoclonal IgE also was shown to be suppressive. These findings suggest that IgG inhibits antibody responses through Fc-independent mechanisms, most likely by masking of antigenic epitopes, thereby preventing B cells from binding and responding to antigen. In agreement with this, we show that T cell priming is not abolished by passively administered IgG. The results have implications for the understanding of in vivo regulation of antibody responses and Rh prophylaxis. (+info)Gonadotropin-releasing hormone analogue conjugates with strong selective antitumor activity. (7/3650)
Conjugation of gonadotropin-releasing hormone (GnRH) analogues GnRH-III, MI-1544, and MI-1892 through lysyl side chains and a tetrapeptide spacer, Gly-Phe-Leu-Gly (X) to a copolymer, poly(N-vinylpyrrolidone-co-maleic acid) (P) caused increased antiproliferative activity toward MCF-7 and MDA-MB-231 breast, PC3 and LNCaP prostate, and Ishikawa endometrial cancer cell lines in culture and against tumor development by xenografts of the breast cancer cells in immunodeficient mice. MCF-7 cells treated with P-X-1544 and P-X-1892 displayed characteristic signs of apoptosis, including vacuoles in the cytoplasm, rounding up, apoptotic bodies, bleb formation, and DNA fragmentation. Conjugates, but not free peptides, inhibited cdc25 phosphatase and caused accumulation of Ishikawa and PC3 cells in the G2/M phase of the cell cycle after 24 h at lower doses and in the G1 and G2 phases after 48 h. Since P-X-peptides appear to be internalized, the increased cytotoxicity of the conjugates is attributed to protection of peptides from proteolysis, enhanced interaction of the peptides with the GnRH receptors, and/or internalization of P-X-peptide receptor complexes so that P can exert toxic effects inside, possibly by inhibiting enzymes involved in the cell cycle. The additional specificity of P-X-peptides compared with free peptides for direct antiproliferative effects on the cancer cells but not for interactions in the pituitary indicates the therapeutic potential of the conjugates. (+info)Continuous axenic cultivation of Pneumocystis carinii. (8/3650)
Continuous axenic culture of Pneumocystis carinii has been achieved. A culture vessel is used that allows for frequent medium exchange without disturbance of organisms that grow attached to a collagen-coated porous membrane. The growth medium is based on Minimal Essential Medium with Earle's salt supplemented with S-adenosyl-L-methionine, putrescine, ferric pyrophosphate, N-acetyl glucosamine, putrescine, p-aminobenzoic acid, L-cysteine and L-glutamine, and horse serum. Incubation is in room air at 31 degrees C. The pH of the medium begins at 8.8 and rises to approximately 9 as the cells grow. Doubling times calculated from growth curves obtained from cultures inoculated at moderate densities ranged from 35 to 65 hours. With a low-density inoculum, the doubling time is reduced to 19 hours. The morphology of cultured organisms in stained smears and in transmission electron micrographs is that of P. carinii, and P. carinii-specific mAbs label the cultured material. Cultured organisms are infective for immunosuppressed rats and can be stored frozen and used to reinitiate culture. (+info)
Immunosuppression - wikidoc
IL-33 modulates inflammatory brain injury but exacerbates systemic immunosuppression following ischemic stroke | VU Research...
Transplant Immunosuppression 2019 | American Society of Transplantation
Cyto-Megalic Virus Information Needed
Esteemed Faculty Presented Latest Evidence on Immunosuppression in CME Outfitters Live Symposium
What is Immunosuppression?
View Source
Publications - Mayo Clinic
Transplantation and immunosuppression - The A Level Biologist - Your Hub
NESPS - Quantifying Brain-death, Transplant Physiology and Immunosuppression on Porcine Muscle-Derived Stem Cell Expansion
Immunosuppressive strategies to avoid complications: The Achilles hee by Gregory Smallwood
5-HT6 Receptors | Discovery of Novel Antigiardiasis Drug
Metastasis is regulated via microRNA-200/ZEB1 axis control of tumour cell PD-L1 expression and intratumoral immunosuppression
Heart Transplantation: Four Years Experience With Conventional Immunosuppression
Multiple Sclerosis Research: Another case of PML on Tecfidera
UC HealthNews : UC Leading First Multicenter Trial Studying Steroid and CNI Immunosuppression Withdrawal Post-Transplant
Combined Immunosuppression in Adults |60 With Crohns Disease
Immunosuppressive properties of purified immune t-interferon. by M A. Lucero, J Wietzerbin et al.
PDF] Selective Immunosuppression by L. Adorini Download Ebook
Targeting CCR2 to Overcome Immunosuppression and Improve Immunotherapy - David Denardo
Aperçu du fichier Immunosuppression in sepsis: a novel understanding of the disorder and a new therapeutic approach par Dr...
Aperçu du fichier Immunosuppression in sepsis: a novel understanding of the disorder and a new therapeutic approach par Dr...
Browsing Farmasøytisk institutt by Author van Le, Truc Thanh
https://www.medicalnewstoday.com/releases/317866.php
Successful readministration of adeno-associated virus vectors to the mouse lung requires transient immunosuppression during the...
Modification of Gene Expression and Protein Profiles by Exhaustive Exercise in Pathogen- stimulated and Un-stimulated...
A Comprehensive and Contemporary Review on Immunosuppression Therapy f by Livia A Goldraich, Santiago A Tobar Leitão et al.
Choices of long-term immunosuppression in renal transplantation: balancing the benefits and risks. : Nephrology Dialysis...
Exhibit Tags: conceptn / Language: English / Subject: Brain Death and Immunosuppression - Reports of the Surgeon General -...
Study demonstrates ability to preserve long-term vision for severe patients with uveitis
Uses of Immunosuppression Therapy in Patients With Liver Transplantation - Full Text View - ClinicalTrials.gov
Uses of Immunosuppression Therapy in Patients With Liver Transplantation - Full Text View - ClinicalTrials.gov
my new islets: Treating the BK virus with lowered immunosuppression
Macrophage-induced reversal of immunosuppression by leukemia viruses. by S C. Specter, M Bendinelli et al.
Alternative Cancer Treatment IL-10 TH2 immunosuppression
Immunosuppression: Concepts And Impacts: Concepts and Impacts, Book by Jim Wang (Hardcover) | chapters.indigo.ca
Beta-O2 Technologies Ltd. | Pre-Clinical
AID 209943 - In vitro evaluation for immunosuppressive activity against proliferation of antigen stimulated murine splenic T...
Kidney Transplantation: Transplant Immunology and Use of Immunosuppression - ONA
CPG WG meeting: Immunosuppression CPG Clinical Consensus | ERN TransplantChild
Biomolecular Markers for Safe Minimization of Immunosuppression - Manikkam Suthanthiran
Virus-Induced Immunosuppression - NDM Research Building
Do Antipsychotics Cause Immunosuppression? - olas bzsnqbpl
FGL2 as a Multimodality Regulator of Tumor-Mediated Immune Suppression and Therapeutic Target in Gliomas
University of Pittsburghs Clinical Experience with Intestine Transplants Featured at International Meeting
Comparison of Induction and Maintenance Immunosuppression Regimens in Intestinal and Multivisceral Transplantation: An Analysis...
Early Changes in Kidney Transplant Immunosuppression Regimens During the COVID-19 Pandemic | Transplant News
Immunosuppression for living donor renal allograft recipients | NefrologÃa (English Edition)
Effects of Zortress + Tacrolimus vs. Standard Immunosuppression on Progression of Coronary Artery Calcifications and Bone...
Bibliography - Biohope
A randomized trial of primary liver transplantation under immunosuppression with FK 506 vs cyclosporine<...
Plus it
Limiting post-transplantation kidney loss - Starfish Innovations
An anti-CD2 mAb induces immunosuppression and hyporesponsiveness of CD2+ human T cells in vitro.
| DIAL.pr - BOREAL
News Related to: Dr. Jianing Fu Abstract Selected by American Transplant Congress | Columbia Center for Translational Immunology
Kaiser Daily Global Health Policy Report | Global Health Conferences and Meetings | Search Results | The Henry J. Kaiser Family...
Coal-Fired Plants | Profile EVS
Immunosuppression, Liver Injury and Post-transplant HCV
STUDIES ON THE NONSPECIFIC DEPRESSION OF THE IMMUNE RESPONSE | JEM
Subject Guide - Immunosuppression - New - Karger Publishers
Immunosuppression and Rejection | University of Illinois Hospital & Health Sciences System
Clinical use of immunosuppressants in transplantation | SpringerLink
sexy male men
Immunosuppressive drug
Immunosuppression. By Randy P Prescilla, MD; accessed on Emedicine.com on 21 August 2005 National Kidney Foundation: A to Z ... Immunosuppression BK virus Behcet's Disease Discovery and development of mTOR inhibitors Treatment methods for preventing organ ... Prolonged use of opioids may cause immunosuppression of both innate and adaptive immunity. Decrease in proliferation as well as ... Muromonab-CD3 can cause excessive immunosuppression. Although CD3 antibodies act more specifically than polyclonal antibodies, ...
Corneal ulcers in animals
Immunosuppression? Cushing's Steroid therapy. Compliance? Is what you've prescribed getting onto the eye? None of the above? ...
COVID-19 pandemic in Austin, Texas
Including people with diabetes; high blood pressure; heart, lung and kidney disease; immunosuppression; obesity; or persons ...
Health management system
December 2002). "Behavioral conditioning of immunosuppression is possible in humans". FASEB J. 16 (14): 1869-73. doi:10.1096/fj ... Ader R, Cohen N (1975). "Behaviorally conditioned immunosuppression". Psychosom Med. 37 (4): 333-40. doi:10.1097/00006842- ... give saccharin paired in a drink with a drug that creates immunosuppression, and later on, giving saccharin alone will produce ... immunosuppression. Such conditioning happens both in experimental rodents and humans. Evolution, according to Nicholas Humphrey ...
Mind-body interventions
Ader R, Cohen N (1975). "Behaviorally conditioned immunosuppression". Psychosomatic Medicine. 37 (4): 333-40. doi:10.1097/ ...
Neural top-down control of physiology
The cerebral cortex in rodents shows lateral specialization in its regulation of immunity with immunosuppression being ... Ader, R.; Cohen, N. (1975). "Behaviorally conditioned immunosuppression". Psychosomatic Medicine. 37 (4): 333-340. doi:10.1097/ ... immunosuppression). After learning this pairing, the taste of saccharin by itself through neural top down control created ... "Behavioral conditioning of immunosuppression is possible in humans". The FASEB Journal. 16 (14): 1869-1873. doi:10.1096/fj.02- ...
Psychoneuroimmunology
Cause immunosuppression which can lead to an extended amount of time fighting off infections. High basal levels of cortisol are ... Behaviorally conditioned immunosuppression. Psychosomatic Medicine, Vol 37, Issue 4 333-340 "Robert Ader, Founder of ... Central mediated since peripheral administration of CRH antagonist does not affect immunosuppression. HPA axis/stress axis ...
Placebo
After learning this pairing, the taste of saccharin by itself is able to cause immunosuppression, as a new conditioned response ... Ader R, Cohen N (1975). "Behaviorally conditioned immunosuppression". Psychosomatic Medicine. 37 (4): 333-40. doi:10.1097/ ... For example, that agent might be cyclophosphamide, which causes immunosuppression. ... immunosuppression, Parkinson's disease and depression. Dopaminergic pathways have been implicated in the placebo response in ...
Health psychology
Ader, R. & Cohen, N. (1975). Behaviorally conditioned immunosuppression. Psychosomatic Medicine, 37(4), 333-340. Matarazzo, J. ...
Thymus
... immunosuppression resulting in infections; or infiltration by cells into parts of the body, resulting in an enlarged liver, ...
Neurosarcoidosis
Treatment is with immunosuppression. The first case of sarcoidosis involving the nervous system was reported in 1905. ...
Muromonab-CD3
Bhorade, S. M.; Stern, E. (2009-01-15). "Immunosuppression for Lung Transplantation". Proceedings of the American Thoracic ...
Lipoarabinomannan
Ellner JJ, Daniel TM (February 1979). "Immunosuppression by mycobacterial arabinomannan". Clinical and Experimental Immunology ...
Thymoma with immunodeficiency
Immunosuppression is sometimes used. The Centers for Disease Control and Prevention recommend pneumococcal, meningococcal, and ...
Bacteria
Heise ER (February 1982). "Diseases associated with immunosuppression". Environmental Health Perspectives. 43: 9-19. doi: ...
John E. Dohms
"Stress-mechanisms of immunosuppression." Veterinary Immunology and Immunopathology 30.1:89-109. 1996. Keeler, C. L., et al. " ...
Pathogenic bacteria
Other bacteria are opportunistic pathogens and cause disease mainly in people with immunosuppression or cystic fibrosis. ... Heise E (1982). "Diseases associated with immunosuppression". Environ Health Perspect. 43: 9-19. doi:10.2307/3429162. JSTOR ...
Ultraviolet index
January 2006). "Ultraviolet immunosuppression: Mechanisms and consequences". Dermatologic Clinics. 24 (1): 19-25. doi:10.1016/j ... immunosuppression, and eye damage, such as cataracts. The scale was developed by Canadian scientists in 1992, and then adopted ...
Merkel cell polyomavirus
Persons with immunosuppression (e.g., AIDS or organ transplant patients) are at higher risk for this cancer and may benefit ... Emergence of a painless lump that expands rapidly, especially among persons over age 50 or persons with immunosuppression, ...
Pneumocystis pneumonia
... immunosuppression, Pneumocystis jirovecii...and the third man". Nature Reviews. Microbiology. 5 (12): 967. doi:10.1038/ ...
Avian immune system
2005) "Immunosuppression threat" World Poultry. 21(2):18-22. Beach RH, Poulos C, Pattanayak SK (2007). "Farm economics of bird ... New studies show that stress is the number one cause of immunosuppression in birds. Stressors leave birds more susceptible to ...
Anthony Hollander
First trachea transplant without immunosuppression , Eureka! Science News Anthony Hollander - University of Liverpool Webpage ...
Polychlorinated dibenzodioxins
Immunosuppression In rodents and fish. The LD50 of dioxin also varies wildly between species with the most notable disparity ...
Chronic pulmonary aspergillosis
Another risk factor is immunosuppression; most commonly, this includes allogeneic stem cell transplantation, prolonged ... there must be a degree of immunosuppression. The microbiological criteria are similar to those of invasive aspergillosis but ...
Włodzimierz Ptak
Ptak W, Gershon RK (1975). "Immunosuppression effected by macrophage surfaces". Journal of Immunology. 115 (5): 1346-50. PMID ...
Howard L. Weiner
"Intensive immunosuppression in progressive multiple sclerosis. A randomized, three-arm study of high-dose intravenous ...
Shingles
Another important risk factor is immunosuppression. Other risk factors include psychological stress. According to a study in ...
Human papillomavirus infection
Dugué PA, Rebolj M, Garred P, Lynge E (January 2013). "Immunosuppression and risk of cervical cancer". Expert Review of ... and immunosuppression. Genital HPV is spread by sustained direct skin-to-skin contact, with vaginal, anal, and oral sex being ... human immunodeficiency virus and immunosuppression". Vaccine. 30 Suppl 5: F168-74. doi:10.1016/j.vaccine.2012.06.045. PMID ...
Pancreas transplantation
After transplantation patients need lifelong immunosuppression. Immunosuppression increases the risk for a number of different ... Advancement in immunosuppression has improved quality of life after transplantation. In most cases, pancreas transplantation is ... During the modern era of immunosuppression, the whole pancreas transplantation technique with enteric diversion became the gold ...
Inhaled ciclosporin
Calne, R (Mar 2004). "Cyclosporine as a milestone in immunosuppression". Transplant. Proc. 36 (2 Suppl): 13S-15S. doi:10.1016/j ... "Improved immunosuppression with aerosolized cyclosporine in experimental pulmonary transplantation". Transplantation. 53 (1): ...
Immunosuppression: Practice Essentials, History, Drugs
Immunosuppression after solid organ transplantation is complex. Over the past 50 years, the medical community has witnessed ... What is immunosuppression after solid organ transplantation?. What has been the evolution of immunosuppression therapy after ... How is immunosuppression after solid organ transplantation maintained during pregnancy?. How is immunosuppression- related BK ... encoded search term (Immunosuppression) and Immunosuppression What to Read Next on Medscape ...
Immunosuppression: Practice Essentials, History, Drugs
Immunosuppression after solid organ transplantation is complex. Over the past 50 years, the medical community has witnessed ... What is immunosuppression after solid organ transplantation?. What has been the evolution of immunosuppression therapy after ... How is immunosuppression after solid organ transplantation maintained during pregnancy?. How is immunosuppression- related BK ... encoded search term (Immunosuppression) and Immunosuppression What to Read Next on Medscape ...
Thwarting galectin-induced immunosuppression in breast cancer
Novel therapeutic strategies are needed to counteract breast cancer-associated immunosuppression. Silencing the expression of ... Thwarting galectin-induced immunosuppression in breast cancer Oncoimmunology. 2013 May 1;2(5):e24077. doi: 10.4161/onci.24077. ... Novel therapeutic strategies are needed to counteract breast cancer-associated immunosuppression. Silencing the expression of ...
Immunosuppression - Simple English Wikipedia, the free encyclopedia
Kidney Transplantation: Transplant Immunology and Use of Immunosuppression - Renal and Urology News
Does this patient have too much or too little immunosuppression?. Choosing the proper immunosuppression for a patient involves ... How should patients with too much or too little immunosuppression be managed?. Too much immunosuppression: Patients on triple ... BK viremia is a disease of over-immunosuppression and is treated mainly by reducing immunosuppression. Studies are under way on ... Too little immunosuppression: Potential approach in increasing immunosuppression include increase target CNI trough, change ...
Immunosuppression | DrugBank Online
EFFECTS OF IMMUNOSUPPRESSION ON WEST NILE VIRUS INFECTION IN HAMSTERS in: The American Journal of Tropical Medicine and Hygiene...
Immunosuppression and experimental virus infection of the nervous system. Adv Virus Res 16 :397-448. ... Immunosuppression and experimental virus infection of the nervous system. Adv Virus Res 16 :397-448. ... Immunosuppression and experimental virus infection of the nervous system. Adv Virus Res 16. :. 397. -448.. ), false ... Immunosuppression and experimental virus infection of the nervous system. Adv Virus Res 16. :. 397. -448.. ), false ...
Mechanisms of Myeloid Immunosuppression: Functional Characterization of the Tumor Microenvironment Using Single and Multiplex...
International Liver Transplantation Society » Education » Working Groups for Immunosuppression Guidance: Immunosuppression...
Role of Immunosuppression in Zoonoses - Public Health - MSD Veterinary Manual
Immunosuppression of breast cancer cells mediated by transforming growth factor-β in exosomes from cancer cells
... *Authors: *Lei ... TGF-β and IL-10 in exosomes are responsible for immunosuppression. Concentrations of (A) TGF-β and (B) IL-10 in exosomes from ... Rong L, Li R, Li S and Luo R: Immunosuppression of breast cancer cells mediated by transforming growth factor-β in exosomes ... Rong, L., Li, R., Li, S., Luo, R.Immunosuppression of breast cancer cells mediated by transforming growth factor-β in exosomes ...
Antimicrobial Prophylaxis for Adult Patients With Cancer-Related Immunosuppression: ASCO and IDSA Clinical Practice Guideline...
Oncology and the Infectious Diseases Society of America on antimicrobial prophylaxis for adult patients with immunosuppression ... Antimicrobial Prophylaxis for Adult Patients With Cancer-Related Immunosuppression: ASCO and IDSA Clinical Practice Guideline ... Antimicrobial Prophylaxis for Adult Patients With Cancer-Related Immunosuppression: ASCO and IDSA Clinical Practice Guideline ... guideline on antimicrobial prophylaxis for adult patients with immunosuppression associated with cancer and its treatment. ...
Immunosuppression - McMaster Experts
Mechanisms of transfusion-associated immunosuppression. Academic Article * Medical Immunosuppression and Outcomes in Cutaneous ... Continued transplant immunosuppression may prolong survival after return to peritoneal dialysis: Results of a decision analysis ... Transplant immunosuppression enhances efficiency of adenoviral-mediated gene retransfection: inhibition of interferon-γ and ... Immunosuppression without calcineurin inhibition: optimization of renal function in expanded criteria donor renal ...
Resistin-induced immunosuppression increases susceptibility to infectious lung injury and sepsis during AKI - Penn State
WHO EMRO | Relation between some haematological abnormalities, degree of immunosuppression and viral load in treatment-naïve...
The degree of cytopenia was directly related to the degree of immunosuppression and clinical AIDS status. No relationship was ... 15]. The degree of thrombocytopenia was also directly related to the degree of immunosupression, in agreement with Jost et al ... Patients with features of AIDS (WHO clinical stage IV) or severe immunosuppression (CD4 count , 200 cells/µL) had lower ... 16] and a multicentre AIDS cohort study showing that anaemia was directly related to the degree of immunosupression [16]. ...
Role of GATA-3 and mir-135a in the exercise induced immunosuppression
Methods: Rats received load exercise to induce immunosuppression. ELIS.. ... This study is to investigate the role of GATA-3 and miR-135a in immunosuppression induced by exercise. ... The fatigue induced by high-intensity exercise may lead to immunosuppression [1]. The exercise induced immunosuppression and ... Role of GATA-3 and mir-135a in the exercise induced immunosuppression. Yujun Zhang1#, Xuewen Tian2, Lei Geng3# and Qinglu Wang3 ...
Chronic morphine-induced MicroRNA-124 promotes microglial immunosuppression by modulating P65 and TRAF6<...
Chronic morphine-induced MicroRNA-124 promotes microglial immunosuppression by modulating P65 and TRAF6. Journal of Immunology ... Chronic morphine-induced MicroRNA-124 promotes microglial immunosuppression by modulating P65 and TRAF6. In: Journal of ... Chronic morphine-induced MicroRNA-124 promotes microglial immunosuppression by modulating P65 and TRAF6. / Qiu, Shuwei; Feng, ... Dive into the research topics of Chronic morphine-induced MicroRNA-124 promotes microglial immunosuppression by modulating P65 ...
"Induction Immunosuppression With Thymoglobulin May Improve Graft Outcomes Without Inc . . ." by Matthew Henry
The aim of this study was to compare outcomes of primary LT patients based on the induction immunosuppression regimens, ... Patients were divided into three groups based on the type of induction immunosuppression utilized, and the outcomes were ... Tacrolimus, mycophenolate mofetil, and steroids were used for maintenance immunosuppression in all three groups. The age of the ... Patients undergoing LT alone with rATG for induction immunosuppression may have improved liver graft survival compared to ...
Weak immune system (immunosuppression)
Neuromyelitis optica relapses: Race and rate, immunosuppression and impairment. - Oxford Neuroscience
... and the effect of immunosuppression on relapse-associated residual disability for transverse myelitis and optic neuritis ... Neuromyelitis optica relapses: Race and rate, immunosuppression and impairment. Tackley G., OBrien F., Rocha J., Woodhall M., ... Cohort study, Devics syndrome, Immunosuppression, Neuromyelitis optica, Adolescent, Adult, African Continental Ancestry Group ... and the effect of immunosuppression on relapse-associated residual disability for transverse myelitis and optic neuritis ...
immunosuppression Archives | The Sumaira Foundation
Pinkbook | General Recommendations | Epidemiology of VPDs | CDC
Severe immunosuppression is a contraindication to live, attenuated vaccines.. *A history of intussusception is a ... Immunosuppression. Live, attenuated vaccines can cause severe or fatal reactions in immunosuppressed persons due to ... A family history of immunosuppression in first-degree relatives (i.e., parents or siblings) is a contraindication to MMR and ... In general, the same vaccination recommendations apply as for other types of immunosuppression. Live-virus vaccines are usually ...
Discussion 9: Process of immunosuppression - App Essay Writers
Discussion 9: Process of immunosuppression. A 34-year-old Hispanic-American male with end-stage renal disease received kidney ... The response includes an accurate, complete, detailed, and specific explanation of the process of immunosuppression and the ... Explain the process of immunosuppression and the effect it has on body systems. ...
THE ROLE OF CHI3L1 IN BREAST CANCER¿A DRIVER OF IMMUNOSUPPRESSION ON THE ROADOF TUMOR PROGRESSION¿ [Tesi di dottorato] - OPAC ...
Deletion of the meq gene significantly decreases immunosuppression in chickens caused by pathogenic marek's disease virus |...
Experimental infection with GX0101ΔMeq showed that deletion of the Meq gene significantly decreased immunosuppression in ... resulting in immunosuppression, which is considered to be an integral aspect of the pathogenesis of Mareks disease (MD). A ... Li, Y., Sun, A., Su, S. et al. Deletion of the meq gene significantly decreases immunosuppression in chickens caused by ... Deletion of the meq gene significantly decreases immunosuppression in chickens caused by pathogenic mareks disease virus. * ...
Nature Immunology
Susceptibility to infectiousCalcineurin InhibitorsRenalChronicTransplantationMechanismsImmune systemSepsisRegimensPatientsZoonosesProgressionInduceImmunotherapy2016ImpairmentOutcomesAntibodyClinicalDiseasesDiabetesRatsEfficacyStrategiesFindingsEffectsRiskRoleCellsMaintenanceEffectExpressionConditionsPotentialAvoidPatientAlternativeSingleGroups
Susceptibility to infectious1
- The exercise induced immunosuppression and increased susceptibility to infectious diseases often result in a decline or stagnation of athlete's performances [ 2 ]. (alliedacademies.org)
Calcineurin Inhibitors3
- Typical antibody-based induction immunosuppression therapy uses antibody preparations directed at T cells in combination with calcineurin inhibitors, antiproliferative agents, and corticosteroids. (medscape.com)
- Calcineurin inhibitors have been a cornerstone of clinical immunosuppression in transplantation since the early 1980s. (medscape.com)
- Thirty percent of those given a PTA will eventually need a renal transplant because of the adverse cumulative effects of immunosuppression with calcineurin inhibitors [ 7 ]. (springeropen.com)
Renal1
- Intermodal immunosuppression for cadaver renal transplantation: results using antilymphocyte globulin, azathioprine, cyclosporine, and prednisone. (mcmaster.ca)
Chronic1
- Other risk factors are smoking, certain sexual practices (frequently changing sexual partners, passive anal sex) and chronic immunosuppression. (krebsdaten.de)
Transplantation2
- Despite the advancement of those concepts over time, this early history shows that immunosuppression was one of the earliest limiting barriers to successful organ transplantation, and remains one of the most significant technical challenges. (asu.edu)
- The life-long immunosuppression associated with transplantation severely impacts both patients health and the transplanted organ itself. (itb-med.com)
Mechanisms1
- The findings have significant implications for understanding the underlying mechanisms of immunosuppression in tumor microenvironments, and for the potential development of cancer therapies. (spandidos-publications.com)
Immune system4
- Immunosuppression means to lower the activity of the immune system . (wikipedia.org)
- Immunosuppression and immunocompromise are the names for what happens when your immune system is weak. (healthinfo.org.nz)
- Further information about having a weak immune system (immunosuppression). (healthinfo.org.nz)
- For IPF we have compelling data that immunosuppression (medicines that suppress your immune system don't work). (pulmonaryfibrosismd.com)
Sepsis1
- It has been reported as causing bacteraemia/sepsis, pneumonia or peritonitis in patients with malignancies, immunosuppression or diabetes. (ksbu.edu.tr)
Regimens2
- The aim of this study was to compare outcomes of primary LT patients based on the induction immunosuppression regimens, including thymoglobulin (rATG), basiliximab, and steroids. (wayne.edu)
- The risk of infection and incidence rates of biopsy proven rejection does not seem to be affected by induction immunosuppression regimens. (wayne.edu)
Patients11
- To provide an updated joint ASCO/Infectious Diseases Society of America (IDSA) guideline on antimicrobial prophylaxis for adult patients with immunosuppression associated with cancer and its treatment. (idsociety.org)
- Patients were divided into three groups based on the type of induction immunosuppression utilized, and the outcomes were compared across groups. (wayne.edu)
- Patients undergoing LT alone with rATG for induction immunosuppression may have improved liver graft survival compared to patients who received basiliximab or steroids only. (wayne.edu)
- Patients with cancer treated with immunotherapy (IO) and those with immunosuppression may have higher rates of cytokine storm due to immune dysregulation. (esmo.org)
- We sought to evaluate the association of IO and immunosuppression with COVID-19 outcomes and cytokine storm occurrence among patients with cancer and COVID-19, based on data from the COVID-19 and Cancer Consortium (CCC19). (esmo.org)
- Administration of IO was not associated with severe outcomes in patients with cancer and COVID-19, whereas pre-existing baseline immunosuppression appears to be independently associated with worse clinical outcomes including cytokine storm. (esmo.org)
- Darling MR, Alkhasawneh M, Mascarenhas W, Chirila A, Copete M. Oral Hairy Leukoplakia in Patients With No Evidence of Immunosuppression: A Case Series and Review of the Literature. (medscape.com)
- 150/90 mmHg), significant cardiovascular impairment or event within previous 12 months or patients who had active autoimmune disease or a medical condition that required immunosuppression. (merck.com)
- With the revolutionizing therapy developed at ITB-MED it has been proved that patients can live a life completely without immunosuppression, with improved quality of life, and at reduced health care costs. (itb-med.com)
- With the therapy developed at ITBMed it has been proven that patients can live a life completely without immunosuppression, leading to improved quality of life and reduced health care costs. (itb-med.com)
- Immunosuppression was associated with poor outcomes among MCC patients: 72% of such MCC patients experienced recurrent disease at a median time of 7.4 months after diagnosis (range, 1-75 months). (uw.edu)
Zoonoses1
- Dogs, zoonoses and immunosuppression. (scielo.br)
Progression1
- However, it is unknown whether immunosuppression type affects progression-free and disease-specific survival. (uw.edu)
Induce2
- Rats received load exercise to induce immunosuppression. (alliedacademies.org)
- Experiment 2 replicated the lack of effect following a single pairing of the CS with the medium dose of cyclophosphamide but demonstrated that three pairings are sufficient to induce conditioned immunosuppression. (edu.pl)
Immunotherapy2
- Abstracts can be submitted on any subject related to Immunosuppression and Immunotherapy. (lifescienceevents.com)
- In contrast, immunotherapy has not shown efficacy in treating glioblastoma, partly due to immunosuppression. (charlieteofoundation.org.au)
20161
- This International Immunosuppression Summit 2016 will bring together scientists to discuss the problems associated with natural and induced immunosuppression. (lifescienceevents.com)
Impairment1
- Neuromyelitis optica relapses: Race and rate, immunosuppression and impairment. (ox.ac.uk)
Outcomes2
- 2020). The association of IO or immunosuppression with the outcomes of interest were evaluated using a multivariable logistic regression balanced for covariate distributions through inverse probability of treatment weighting (IPTW). (esmo.org)
- In recapitulating the complex interactions associated with autoimmune biology such as T and B cell activation, immune modulation, immunosuppression, T cell skewing, inflammation and tissue remodeling, this panel provides an effective and efficient in vitro model for interrogating in vivo drug activities to predict potential outcomes with respect to drug efficacy and safety. (discoverx.com)
Antibody1
- Long-term outcome of anti-glomerular basement membrane antibody disease treated with plasma exchange and immunosuppression. (elsevier.com)
Clinical1
- The influence of clinical features on annualised relapse rates (using multiple regression) and the effect of immunosuppression on relapse-associated residual disability for transverse myelitis and optic neuritis attacks (using a mixed effect model) were analysed. (ox.ac.uk)
Diseases1
- To recap: The government says women are more likely to get immunosuppression diseases but denies that they are real diseases with a valid biologic cause and says to "treat the symptoms" with pharmaceuticals even though such drugs are contraindicated for, and can even cause death in, this patient population. (badlymeattitude.com)
Diabetes1
- Underlying pathologies that predispose to fungal nail infections: peripheral circulatory disorders, diabetes mellitus and immunosuppression. (farmacianovadamaia.pt)
Rats1
- In three experiments, rats were exposed to a gustatory conditioned stimulus (CS) paired with cyclophosphamide (US), which induces immunosuppression and malaise. (edu.pl)
Efficacy1
- 2012). Corticosteroid-Induced Immunosuppression Ultimately Does Not Compromise the Efficacy of Antibiotherapy in Murine Mycobacterium ulcerans Infection . (up.pt)
Strategies1
- Novel therapeutic strategies are needed to counteract breast cancer-associated immunosuppression. (nih.gov)
Findings1
- These findings indicate that conditioned immunosuppression effects can be enhanced in magnitude through the use of certain procedural techniques. (edu.pl)
Effects1
- Opioids have been widely applied in clinics as one of the most potent pain relievers for centuries, but their abuse has deleterious physiological effects including immunosuppression. (elsevier.com)
Risk2
- Choosing the proper immunosuppression for a patient involves balancing the risk of immunologic graft injury against the risks of infection and malignancy. (renalandurologynews.com)
- Individuals with immunosuppression are not thought to be at an increased risk of contracting COVID - 19. (stpancrasclinicalresearch.com)
Role2
- This study is to investigate the role of GATA-3 and miR-135a in immunosuppression induced by exercise. (alliedacademies.org)
- The direct relationship between MDV strains of higher pathogenicity and greater immunosuppression [ 4 ] suggest that Meq perhaps plays an important role in immunosuppression. (biomedcentral.com)
Cells3
- The imbalance of T-lymphocyte differentiation, especially the helper T cells (Th cells), is an important factor in exercise induced immunosuppression [ 4 ]. (alliedacademies.org)
- Marek's disease virus (MDV) causes an acute lymphoproliferative disease in chickens, resulting in immunosuppression, which is considered to be an integral aspect of the pathogenesis of Marek's disease (MD). A recent study showed that deletion of the Meq gene resulted in loss of transformation of T-cells in chickens and a Meq-null virus, rMd5ΔMeq, could provide protection superior to CVI988/Rispens. (biomedcentral.com)
- Homeostatic repopulation by CD28-CD8+ T cells in alemtuzumab-depleted kidney transplant recipients treated with reduced immunosuppression. (ox.ac.uk)
Maintenance1
- Tacrolimus, mycophenolate mofetil, and steroids were used for maintenance immunosuppression in all three groups. (wayne.edu)
Effect2
- Explain the process of immunosuppression and the effect it has on body systems. (appessaywriters.com)
- Experiment 3 demonstrated that significant immunosuppression is observable following a single CS?US pairing if the CS is presented in compound with a previously nonreinforced CS during training, an effect reminiscent of supernormal conditioning. (edu.pl)
Expression2
- In the exercise induced immunosuppression, the expression levels of many miRNAs and proteins are changed [ 14 ]. (alliedacademies.org)
- In this study, qRT-PCR, Western blot, ELISA and dual luciferase assay were used to detect the cytokines, spleen index, and gene and protein expression in spleen in the exercise induced immunosuppression rat model. (alliedacademies.org)
Conditions2
- The same advice would apply to individuals with conditions causing immunosuppression. (stpancrasclinicalresearch.com)
- The goal of this study was to define conditions under which conditioned immunosuppression may be observed reliably. (edu.pl)
Potential1
- In vitro Treg expansion was a simple and effective strategy for generating autologous Treg and highlighted a potential adoptive Treg cell therapy to suppress antigraft T-cell responses and reduce the requirement for immunosuppression in islet xenotransplantation. (diabetesjournals.org)
Avoid1
- They deux to avoid consider exclusively world, infected livestock, a immunosuppression) mL and day) in examination host ARL. (aundm-reifen.de)
Patient1
- Does this patient have too much or too little immunosuppression? (renalandurologynews.com)
Alternative1
- In this trial, SRL-based immunosuppression was a safe alternative to CNI. (elsevier.com)
Single1
- In Experiment 1, a single pairing of the CS with low, medium, or high doses of cyclophosphamide in separate groups produced no reliable conditioned immunosuppression even though conditioned taste aversion was observed in groups trained with high and medium doses of CY. (edu.pl)
Groups1
- Working Groups for Immunosuppression Guidance: Immunosuppression. (ilts.org)